Related by context. All words. (Click for frequent words.) 59 Six3 59 HHV 6 59 microbial pathogenesis 59 prostate carcinogenesis 59 kidney urologic 58 oncogenesis 58 underlying molecular mechanisms 58 chitinase 58 Wnt signaling pathway 58 Dr. Bezprozvanny 58 biologic pathways 58 molecular pathogenesis 58 beta defensins 57 diagnostic biomarkers 57 idiopathic pulmonary 57 viral pathogenesis 57 immunobiology 57 IRF6 56 Renata Pasqualini 56 Neuro Oncology Program 56 Developmental Therapeutics Program 56 Iruela Arispe 56 Prox1 56 Matthew Meyerson 56 George Coukos 56 Hakon Hakonarson 56 immunopathology 56 C. pneumoniae 56 Virend Somers MD Ph.D. 56 Pier Paolo Pandolfi 56 PEDF 56 pathogenetic mechanisms 55 NF kB pathway 55 antibody mediated 55 Giaccia 55 myeloproliferative disorders 55 OSUCCC James 55 eotaxin 55 A3 adenosine receptor 55 cardio metabolic diseases 55 Mayo Clinic oncologist 55 Cancer Immunobiology Center 55 breast cancer metastasis 55 immunoregulation 55 Einstein Montefiore 55 cardiometabolic disorders 55 epigenetic therapies 55 Akt3 55 Tlsty 55 CMV vaccine 55 Irva Hertz Picciotto 55 prognostic markers 55 Breast Oncology 55 DFCI 55 Victor Velculescu 55 immunological mechanisms 55 Dr. Pasinetti 54 Dennis Steindler 54 hedgehog pathway 54 Singh Manoux 54 Hakonarson 54 immunoregulatory 54 BARI 2D 54 Jorge Cortes MD 54 Richard Schilsky 54 apoE 54 protein tyrosine kinase 54 TMEM#B 54 angiogenesis inhibition 54 Ari Melnick 54 Alvine Pharmaceuticals 54 Christos Mantzoros 54 acute humoral rejection 54 cancer chemoprevention 54 Dr. Pestell 54 Therapeutic antibodies 54 Dr. Victor Velculescu 54 Neurodegenerative 54 miRagen 54 DeKosky 54 GRNCM1 54 Dr. Rafii 54 NINR 54 EGFR pathway 54 DiaKine 54 malignant lymphomas 54 epigenetic mechanisms 54 lipoprotein metabolism 54 Dr. Koenekoop 54 neuro developmental disorders 54 engineered RAP peptides 54 Jay Kolls 54 Marbán 54 ADAM# 54 NR#A# 54 immune modulating 54 cAMP pathway 54 Tony Wyss Coray 53 Massagué 53 Dr. Hakon Hakonarson 53 Arul M. 53 Caris MPI 53 gastro intestinal inflammation 53 sonographic diagnosis 53 Mayo Clinic rheumatologist 53 Shiekhattar 53 Mayo Clinic hematologist 53 fibrocytes 53 Arnold Kriegstein 53 Gutmann MD Ph.D. 53 depsipeptide 53 pediatric pulmonology 53 Celator 53 d' Azzo 53 Ascherio 53 mGluR2 NAM 53 Hotamisligil 53 pathogenic mechanisms 53 Cascade LifeSciences 53 Rowitch 53 Galectin 3 53 protein misfolding diseases 53 Van Den Eeden 53 IGFBP2 53 MCPIP 53 Neuroimmunology 53 bone metabolism 53 ORWH 53 Margaret Pericak Vance 53 cardio metabolic 53 cardiac hypertrophy 53 antiviral compounds 53 Teriflunomide 53 Amir Lerman 53 Epstein Barr Virus EBV 53 chemopreventive agents 53 William Sandborn MD 53 Richard Smeyne 53 Dr. Massimo Cristofanilli 53 Kenneth Kinzler 53 Sodroski 53 inhibit metastasis 53 Shelton Earp 53 Pericak Vance 53 stratifying patients 53 gastrointestinal malignancies 53 chronic renal disease 53 Nurr1 53 Shoelson 53 COX enzymes 53 TCF#L# gene 53 miRagen Therapeutics 53 neuropsychiatric diseases 53 beta1 integrin 53 MD FACS FAAP 53 adult mesenchymal stem 53 HepaLife 53 Patricia Hartge 53 MD DPhil 53 transplantation immunology 53 oncomodulin 53 Dr. Fehlings 53 PARP inhibition 53 LPA1 53 Tarvacin Anti Viral 53 NV1FGF 53 FGFs 53 childhood leukemias 53 myeloproliferative neoplasms MPNs 53 Sudhir Agrawal D.Phil 53 UM Comprehensive Cancer 53 Lambris 53 Eric Kossoff 53 Soengas 53 DGAT 53 pathobiology 53 MEK inhibitors 53 CytomX 53 squamous cell lung cancer 53 Lennart Mucke MD 53 peroxisomal 53 etiologic factors 53 podocyte 53 epigenomics 52 NIAMS 52 neuroimmunology 52 cholesterol metabolism 52 orofacial 52 hypoxic tumors 52 Pseudomonas aeruginosa infections 52 dermatological disorders 52 Charis Eng 52 Kuppermann 52 TrialNet 52 VCFS 52 sortilin 52 BIIR 52 Dr. Nabel 52 Cedars Sinai Maxine Dunitz 52 diagnose coronary artery 52 molecular epidemiology 52 Massimo Cristofanilli MD 52 obesity insulin resistance 52 cathepsin K 52 Tom Misteli 52 CXCR7 52 Ph.D. D.Sc. 52 Metabolic Disease 52 Tiganis 52 Joel Elmquist 52 resolvins 52 Prolla 52 Dr. Vitetta 52 Prediman K. Shah 52 Autoimmune disorders 52 Paul Sanberg 52 HGPS 52 Monoclonal antibody 52 small molecule activators 52 inherited metabolic disorders 52 tumor immunology 52 Viral Immunotherapy platform 52 chromium supplementation 52 sickle cell hemoglobin 52 tissue fibrosis 52 FACMG 52 thromboembolic disease 52 Dr. Ivashkiv 52 lipid metabolites 52 Mayo Clinic neurologist 52 Guoping Feng 52 USP# 52 mitochondrial dysfunction 52 underlying pathophysiology 52 neurology immunology 52 Micro RNAs 52 THR beta agonist 52 #q# deletion 52 tumor metastasis 52 LaFerla 52 node metastasis 52 lung fibrosis 52 Dementias 52 genetic epidemiology 52 radioimmunotherapy RIT 52 vascular biology 52 molecular underpinnings 52 retinoid X 52 JAK3 52 genitourinary oncology 52 pharmacogenetic testing 52 myogenesis 52 aP2 52 CB2 receptor 52 p#/CBP 52 innate immune 52 Nalini Ranjit 52 Pi Sunyer 52 Stem Cell Innovations 52 Dr. Denise Faustman 52 Neurovirology 52 therapeutic monoclonal antibody 52 cathepsins 52 potentially modifiable 52 clinicopathological 52 atypical hemolytic uremic syndrome 52 Logical Therapeutics 52 infectious diseases immunology 52 journal Nature Immunology 52 chemopreventive agent 52 antimetastatic 52 HH GLI 52 EDRN 52 nonhuman primate model 52 immunological diseases 52 Fibroblast 52 neovascularisation 52 mda 7 52 Nickolas Papadopoulos 52 endocrinology metabolism 52 Darley Usmar 52 Myelodysplastic syndromes MDS 52 SCDAA 52 Diana Schendel 52 Eric Nestler 52 El Deiry 52 renal fibrosis 52 p# MAPK 52 intracellular bacteria 52 Bert Vogelstein 52 CALGB 52 epithelial cancers 52 proliferative diseases 52 mtDNA mutations 52 Dr. Javitt 52 ACRIN 52 Dr. Sosne 52 molecular determinants 52 UTHealth 52 Kimmie Ng 52 Bengt Winblad 52 Velcura 51 Mayo Clinic urologist 51 Massague 51 HPCGG 51 serine proteases 51 haematological cancers 51 multiple sclerosis psoriasis 51 FASgen 51 Dr. Eugene Braunwald 51 Wactawski Wende 51 isoform selective 51 Gruber MD Ph.D. 51 molecular abnormalities 51 cathepsin 51 neuroinflammation 51 HDL Selective Delipidation 51 Hans Clevers 51 intracellular signaling pathways 51 DMD DMSc 51 STK# gene 51 PGRN 51 uPA 51 Lankenau Institute 51 dermatologic diseases 51 antisense inhibitors 51 Olefsky 51 Trophos 51 hypereosinophilic syndrome 51 Immune Tolerance Network 51 Genetic variants 51 epigenetic modification 51 histone deacetylase 51 intercellular signaling 51 MassGeneral Institute 51 MD hematologist 51 oncogenic HPV 51 cellular immunotherapy 51 hereditary predisposition 51 imatinib resistance 51 Bone Marrow Transplantation 51 Vector Borne 51 ALI ARDS 51 investigational therapies 51 RNA silencing 51 Benjamin Movsas MD 51 Dr. McHutchison 51 LMNA 51 Edenberg 51 predictive toxicology 51 Kidney Disorders 51 preclinically 51 synaptogenesis 51 Nod1 51 pathological hallmarks 51 journal Pediatric Allergy 51 Aravinda Chakravarti Ph.D. 51 genetic polymorphisms 51 Chronic lymphocytic leukemia 51 hematologist oncologist 51 Südhof 51 TSLP 51 novel peptide 51 urologic oncology 51 biochemical mechanisms 51 Thomas Ichim 51 journal Arteriosclerosis Thrombosis 51 SIgN 51 cell signaling pathways 51 Inosine 51 Cenomed 51 Lennart Mucke 51 epigenetic regulation 51 MD Ph.D. Mayo Clinic 51 fibrogenesis 51 Alpha synuclein 51 CALHM1 51 signal transduction inhibitors 51 Lpathomab 51 MD Dr.PH 51 calcium calmodulin dependent 51 susceptibility loci 51 Lewis Cantley 51 inherited retinal 51 VHL gene 51 cytomegalovirus CMV 51 BioSET 51 Wadih Arap 51 UOHI 51 Critchfield MD 51 Metastatic Colon Cancer 51 Merajver 51 MD D.Phil 51 antiphospholipid antibodies 51 microRNA miR 51 LKB1 51 Polychronakos 51 motor neuron degeneration 51 immunotoxins 51 metabonomics 51 Acetyl L carnitine 51 Gastroenterology Hepatology 51 Randi Hagerman 51 Experimental Neurology 51 hemoglobinopathies 51 Gheorghiade 51 Dr. Ramilo 51 NOMID 51 Wnt pathway 51 Dale Umetsu 51 Karlseder 51 Curemark 51 prognostic biomarkers 51 Giulio Maria Pasinetti 51 mitochondrial disorders 51 Shahin Rafii 51 environmental toxicants 51 adipose derived stem cells 51 immuno oncology 51 insulin signaling pathways 51 endocrinology diabetes 51 Caris Diagnostics 51 Agus MD 51 hepatobiliary 51 autism susceptibility genes 51 experimental therapeutics 51 axon regeneration 51 CDK inhibitors 51 Cylene Pharmaceuticals 51 Smad3 51 cardioprotective effects 51 bronchopulmonary dysplasia BPD 51 myelin repair 51 plasma kallikrein 51 chronic granulomatous disease 51 immunodeficiencies 51 mastocytosis 51 leukotriene pathway 51 bioinformatician 51 Bafetinib 51 ependymoma 51 biochemical abnormalities 51 genomic alterations 51 Naurex 51 microRNA expression 51 Innovive Pharmaceuticals 51 pathogenesis 51 Experimental Hematology 51 cardio renal 50 Capsulution 50 Pediatric Allergy 50 M. Gotto 50 Affimed Therapeutics AG 50 ENMD # 50 thalidomide Thalomid 50 muscular dystrophies 50 Guillermo Torre Amione 50 leukocyte recruitment 50 Wolf Reik 50 Sekaly 50 Leber Hereditary Optic Neuropathy 50 Alton Boynton 50 PIK3CA 50 multifactorial disease 50 venous malformations 50 Helicobacter 50 Abram Hoffer 50 RNA splicing 50 Paul Aisen 50 Creabilis Therapeutics 50 predisposing factors 50 benign prostatic hypertrophy BPH 50 S. maltophilia 50 VIRxSYS 50 aetiological 50 primary cilia 50 Villejuif France 50 Shlipak 50 Vincent Cogliano 50 autoantigen 50 Autoimmune diseases 50 Reddien 50 hyperparathyroidism 50 David Schenkein MD 50 SomatoKine 50 Velculescu 50 mGluR5 antagonist 50 Caris Dx 50 MD tells WebMD 50 cytomegalovirus infection 50 asthma allergic rhinitis 50 Pim kinases 50 immunologic responses 50 NIGMS 50 immuno therapeutic 50 Experimental Therapeutics 50 TRAIL induced apoptosis 50 Mayo Clinic gastroenterologist 50 GATA4 50 Reinherz 50 RNAi therapeutic targeting 50 Genetic variations 50 OHR/AVR# 50 GMX# 50 simplex virus 50 ERBB4 50 Lenore Launer 50 Dr. Dinarello 50 endocrinology gastroenterology 50 GIND 50 lymphomas leukemias 50 GRP# 50 immunomodulation 50 UCLA Jonsson Cancer 50 biologic plausibility 50 Jerome Lipper 50 Matchar 50 Dr. Tashkin 50 cellular pathways 50 James Cerhan MD 50 TransMolecular 50 Alan Guttmacher 50 ADPKD 50 Piccart 50 Daviglus 50 TGF β 50 intestinal microbiota 50 Oxidative damage 50 Fikrig 50 Cryptococcus neoformans 50 Ception Therapeutics 50 novel therapeutic antibodies 50 Roger Perlmutter Amgen 50 Werner Hacke 50 Langerhans cell histiocytosis 50 C EBP alpha 50 mediated inhibition 50 Lisa Mosconi 50 focal adhesion kinase 50 Sc.D. MPH 50 FGFR3 50 ImmunoCellular Therapeutics 50 Osteopontin 50 Jose Baselga 50 Karayiorgou 50 myeloproliferative neoplasms 50 myeloproliferative diseases 50 thromboxane A2 50 Dr. Abhimanyu Garg 50 focal adhesion kinase FAK 50 atopic march 50 gastric carcinoma 50 Froguel 50 metabolic dysfunction 50 Squalamine 50 Src inhibitors 50 lymphangiogenesis 50 Diabetes Endocrinology 50 type 1diabetes 50 Neuro oncology 50 CCCEH 50 Afatinib 50 Bart De Strooper 50 eosinophilic inflammation 50 Fatty Liver Clinic 50 Samuel Wickline 50 TPI ASM8 50 ADAMTS# 50 oligodendrogliomas 50 Aerie Pharmaceuticals 50 psoriatic arthritis PsA 50 Epstein Barr virus EBV 50 NIAID Laboratory 50 LAB CGRP 50 PKM2 50 Joseph Loscalzo 50 Aviptadil 50 AA Amyloidosis 50 molecular biomarkers 50 erythropoietic 50 Manja Bouman CEO 50 periodontal diseases 50 genetic determinants 50 Noscira 50 fibrotic disease 50 Autoimmune Disease 50 developmental neurobiology 50 Johan Auwerx 50 GATA3 50 Aballay 50 Getzenberg 50 testicular germ cell 50 SIADH 50 Zolopa 50 Digestive Diseases 50 abnormal p# 50 NIDCR 50 Cardiovascular Genetics 50 metastatic lymph nodes 50 cachexia anti infectives 50 Marc Tessier Lavigne 50 gastrointestinal dysfunction 50 genetic modifiers 50 Survivorship Program 50 eosinophilic esophagitis 50 Christoph Westphal MD Ph.D. 50 Inflammatory bowel diseases 50 bile acid metabolism 50 IDH1 mutation 50 microRNA biomarkers 50 E#F# 50 Biodesix 50 Bone Biologics 50 MD Ph. D. 50 Cutaneous Oncology 50 Fanconi syndrome 50 Eric Van Cutsem 50 apo E 50 Simin Nikbin Meydani 50 PKCi 50 Dolores Malaspina 50 Joan Massagué 50 adenosine A2A 50 Dr. Karsenty 50 fibrotic diseases 50 SCD1 50 diseases fat malabsorption 50 AEHA 50 MAPCs 50 Loeys Dietz syndrome 50 Izpisúa Belmonte 50 Fehlings 50 cyclophilin inhibitors 50 Kalantar Zadeh 50 H. pylori infection 50 Tschöp 50 Luis Parada 50 metalloprotease 50 Dendritic cell 50 Bryostatin 50 novel immunotherapies 50 NS5A 50 Chemoprevention 50 FoxO1 50 EVGN 50 Pediatric Neurology 50 Dr. Chodick 50 inhibit viral replication 50 severely immunosuppressed 50 Curaxin 50 Immunobiology 50 antisense inhibitor 50 Wynshaw Boris 50 Monoclonal 50 Molecular Epidemiology 49 Fredberg 49 amyloid formation 49 Thoracic Oncology 49 Rienhoff 49 Stephen Kingsmore 49 Naresh Punjabi 49 Smeyne 49 biologic therapeutics 49 novel immunotherapeutic 49 Allergy Cardiovascular 49 vivo pharmacology 49 Idiopathic Pulmonary Fibrosis 49 pediatric hematologist 49 Hurler syndrome 49 regenerative biology 49 Dr. Ziyad Hijazi 49 etiologic 49 MD Sc.D. 49 Pediatric Inflammatory Bowel Disease 49 Rebecca Garten 49 oncology virology 49 Dr. Ruoslahti 49 molecular mechanisms underlying 49 Cardiovascular Epidemiology 49 Monique MB Breteler 49 respiratory gastrointestinal 49 SSc 49 MD Ph.D. Kosan 49 Candidiasis 49 Claudia Henschke 49 Aquinox 49 SHANK3 gene 49 meningeal 49 osteopontin OPN 49 Factor Receptor 49 anticancer therapeutics 49 genetic loci 49 VEGF receptor 49 renoprotective 49 Di Bisceglie 49 medulloblastomas 49 M.D. Ph.D. 49 NPHP 49 familial pancreatic cancer 49 c myc gene 49 preferentially bind 49 UT Southwestern researchers 49 ProNAi 49 NAEPP 49 Schlaggar 49 narcolepsy cataplexy 49 primary hyperparathyroidism 49 EGEN 49 smoldering myeloma 49 CorMatrix 49 autosomal dominant polycystic kidney 49 Ph.D MPH 49 Clive Svendsen 49 Dr. Kandzari 49 PTEN mutations 49 Polycythemia vera 49 Cornea Donor Study 49 Glioblastoma Multiforme GBM 49 Entamoeba histolytica 49 recombinant plasma 49 ANCA associated 49 DGAT1 49 proteomic technologies 49 Daniel M. Skovronsky 49 MMP inhibitors 49 immuno modulatory 49 TTR amyloidosis 49 Paediatric Allergy 49 journal Molecular Psychiatry 49 Daniel Junius 49 LRP1 49 Chapkin 49 Macklis 49 glioblastoma tumor 49 Owen Hendley pediatrician 49 NIAID Vaccine Research 49 pathophysiological 49 allergic diseases 49 Grigori Enikolopov 49 immunomodulatory properties 49 DBV Technologies 49 Nussenzweig 49 adipose derived regenerative 49 Orrin Devinsky MD 49 Joan Massague 49 asthma COPD Chronic 49 GPx 49 sporadic ALS 49 Sc.M. 49 HuCNS SC ® 49 PhD UCSF 49 neurotrophic 49 synaptic function 49 virulence genes 49 Marc Weisskopf 49 telomere biology 49 Cathepsin B 49 Li Huei Tsai 49 autoimmunity 49 PLoS ONE journal 49 molecular profiling 49 Dr. Gianni Belcaro 49 highly selective inhibitor 49 ARF1 49 Albert M. Kligman 49 NewYork-Presbyterian/Columbia 49 Dr. Von Hoff 49 Neurosurgical Institute 49 Bresalier 49 oral ghrelin agonist 49 Talpaz 49 Autoimmunity 49 allergen avoidance 49 Pulmonary Allergy 49 Shiuan Chen 49 Pasarica 49 vivo validation 49 Dr. Dadachova 49 Lynda Chin 49 genomic profiling 49 EGFR blockers 49 extramedullary 49 Pervasis 49 ANAVEX 49 Martin Nicklasson CEO 49 Nutrition Metabolism 49 Arno Therapeutics 49 Proneuron 49 Bettuzzi 49 PharmaFrontiers 49 diagnostic biomarker 49 vascular disrupting agents 49 t2cure GmbH 49 pre mRNA splicing 49 Silodosin 49 Cancer Immunotherapy 49 hematological diseases 49 allergic inflammation 49 dyslipidemias 49 Intervention Trial GAIT 49 ProLindac TM 49 ProtoKinetix 49 dietary acrylamide 49 Hakon Hakonarson MD Ph.D. 49 Emory Winship 49 MGH CEM 49 tumorigenesis 49 Malassezia 49 PhD DSc 49 NKX#.# 49 Provectus Pharmaceuticals specializes 49 p#NTR 49 ultrastructure 49 EGIR 49 upregulates 49 OPHN1 49 Digital Mammographic Imaging 49 systemic amyloidosis 49 Ploegh 49 interleukin 1beta 49 Matthay 49 humanized monoclonal antibodies 49 previously undescribed 49 pemphigus 49 tumor suppressor protein 49 ABL1 49 cardiovascular anti infectives 49 Dr. Ellen Vitetta 49 TGF ß 49 CSHL Professor 49 vitro pharmacology 49 immunological 49 breast endometrial 49 JAK kinases 49 Georges Gemayel 49 Cytochrome P# 49 sickle cell disease 49 Dr. Gary Noskin 49 MD pediatric cardiologist 49 K ras mutations 49 Lp PLA 2 49 Hutchinson Gilford progeria 49 Kozyrskyj 49 SNT-MC#/idebenone 49 Okunieff 49 anti angiogenic drugs 49 molecular pathway 49 Steven Galson MD MPH 49 DeBakey VA Medical 49 David Sidransky 49 proliferative disorders 49 Mutational 49 MYH9 gene 49 GlgE 49 causal pathways 49 UHCMC 49 Eisenmenger syndrome 49 Dr. Grekos 49 neurexins 49 pediatric nephrologist 49 Dr. Harshfield 49 MAGE A3 ASCI 49 Edward Lanphier Sangamo 49 Vascular Biology Program 49 Paul Muntner 49 MAPK pathway 49 Estrogen Receptor 49 Kaeberlein 49 Ravgen 49 Translational Genomics 49 mitochondrial toxicity 49 Raymond T. Bartus 49 Rimoin 49 number NCT# ClinicalTrials.gov 49 BioRexis 49 Amy Abernethy 49 GSK3 49 PRESEPT Study 49 pancreatic adenocarcinoma 49 OHSU Doernbecher 49 NHGRI Division 49 antifibrotic 49 IGSP 49 von Hippel Lindau 49 Chanock 49 Elizabeth Nabel 49 Alzheimer Disease AD 49 Peer Reviewed Medical 49 Braunwald 49 immuno inflammatory 49 endophenotypes 49 FMRP protein 48 Molly Wagster 48 MGH Cancer 48 thrombophilia 48 selenium supplementation 48 neurite outgrowth 48 Microbial Pathogenesis 48 Oncologic 48 Kv#.# 48 von Willebrand disease 48 prostaglandin synthesis 48 EBV infection 48 colorectal tumor 48 ImmuneRegen BioSciences 48 sphingolipids 48 Fc receptor 48 Angiocept 48 Cooper DeHoff 48 Polymorphisms 48 peptide therapeutics 48 Retrovirus 48 mTOR signaling pathway 48 Amorcyte 48 bronchial epithelial cells 48 Lodamin 48 diagnosing ADHD 48 JAK1 48 WAIMR 48 Marji McCullough 48 F. Holick 48 5q deletion 48 druggable targets 48 sphingolipid 48 Cell Transplantation 48 interventional neuroradiology 48 systemic sclerosis SSc 48 Marambaud 48 neuro degenerative diseases 48 neuropathologists 48 Cholesterol Levels SPARCL 48 cAMP signaling 48 dietary interventions 48 â catenin 48 Semafore 48 Abecasis 48 Bexion 48 infantile colic 48 Rasenick 48 PON1 activity 48 melanocortin receptor 48 HMG CoA reductase inhibitors 48 diabetic cardiomyopathy 48 Bisphosphonate 48 vaso occlusive crisis 48 non ulcer dyspepsia 48 beta interferons 48 neuro oncologist 48 nonalcoholic steatohepatitis 48 Neurogenetics 48 CRTC3 48 pathogen interactions 48 genetics immunology 48 molecular pathology 48 5 hydroxymethylcytosine 48 Zlokovic 48 endovascular neurosurgery 48 OCT4 48 innate immunity 48 Mootha 48 translational neuroscience 48 Cyclin E 48 Tait Shanafelt MD 48 targeted radiotherapeutics 48 GVAX ® 48 Skordalakes 48 mechanistic studies 48 cervical neoplasia 48 Tesmilifene 48 Omenn 48 GPC3 48 RIP1 kinase 48 Todd Kuiken 48 Burzynski Clinic 48 lymphatic vasculature 48 pediatric endocrinology 48 UTHSCSA 48 hedgehog signaling pathway 48 pathophysiological mechanisms 48 Oparil 48 recurrent glioblastoma multiforme 48 endometriosis ovarian cysts 48 Zilkha Neurogenetic Institute 48 Singulex 48 P#X# receptor 48 Regado Biosciences 48 statins cholesterol lowering 48 Ronald DePinho 48 eosinophilic disorders 48 SIRT1 gene 48 Reefhuis 48 Vascugel R 48 Bairey Merz 48 myotonic dystrophy 48 thymosin beta 4 48 multisystem disease 48 CBLC# 48 LIAI 48 INSPIRE Trial Phase III